Lynne’s Perspective
Don’t Hold Back: Ask Your Doctor Everything

After her diagnosis in 2005, Lynne went through 3 tyrosine kinase inhibitors (TKIs) for Ph+ CML in chronic phase before joining the clinical trials for SCEMBLIX in 2015. She encourages patients who are struggling with side effects or falling short of treatment goals to ask their doctor if it’s time for a different medication.

Please note, Lynne cannot provide clinical advice or counseling. For medical questions, speak with your doctor.

Lynne is an actual patient who has been compensated by Novartis Pharmaceuticals Corporation for participating in the SCEMBLIX Peers program.

Expand all

Is CML a “good cancer?”

What results have you seen with SCEMBLIX?

What is SCEMBLIX and what are the possible side effects?

How did you feel when you realized the second or third TKI was not working?

If a second or third TKI isn’t working, why might someone hesitate to switch?

Why have you had to switch TKIs multiple times?

How important is the patient-doctor relationship?

What can someone do if they're not doing well on their TKI?

Have you ever thought twice about discussing side effects with your doctor?

How do you discuss side effects with your doctor?

Have you set any treatment milestones with your doctor?

What would you say to someone who is not meeting their milestones?

Do you have any concerns when you go for blood tests?

Where can CML patients and caregivers find support?

What financial support options are available for eligible SCEMBLIX patients?

Can patients starting on SCEMBLIX receive one-on-one support?


Get the perspective of another SCEMBLIX Peer.

Hear about Al’s Experience >